Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK

Background: Venous thromboembolism (VTE), which includes pulmonary embolism (PE) and deep vein thrombosis (DVT), is the third most common acute cardiovascular disease and represents an important burden for patients and payers. Objective: The aim was to estimate the cost-effectiveness of edoxaban, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Clay, Emilie, Jamotte, Aurélien, Verhamme, Peter, Cohen, Alexander T., Van Hout, Ben. A., Gumbs, Pearl.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052426/
https://www.ncbi.nlm.nih.gov/pubmed/30034645
http://dx.doi.org/10.1080/20016689.2018.1495974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052426/
https://www.ncbi.nlm.nih.gov/pubmed/30034645
http://dx.doi.org/10.1080/20016689.2018.1495974

Ejemplares similares